14 results
10-K
2021 FY
EX-10.41
CRBU
Caribou Biosciences Inc
21 Mar 22
Annual report
4:19pm
recruitment, interviews, or pre-employment negotiations, whether written or oral. In the event of a conflict between the terms and provisions
10-K
2021 FY
EX-10.33
CRBU
Caribou Biosciences Inc
21 Mar 22
Annual report
4:19pm
to, any representations made during your recruitment, interviews or pre-employment negotiations, whether written or oral. Any amendment of this Offer Letter
S-3
CRBU
Caribou Biosciences Inc
9 Aug 22
Shelf registration
12:00am
Unlimited Company in February 2021;
inability to obtain additional collaboration partners;
the recruitment and retention of key personnel;
the level
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
and process for identifying patients; design of the clinical trial protocol; regulatory hold on clinical trial recruitment because of unexpected safety … . Even if we demonstrate that such SAEs are not product candidate-related, such occurrences could affect patient recruitment or the ability of enrolled
ARS
ss0f9gc6vpmvp9e5f
28 Apr 23
Annual report to shareholders
12:00am
10-K
w1nq52m3 71wwti09
21 Mar 22
Annual report
4:19pm
DRS
80ntrq2gye
7 May 21
Draft registration statement
12:00am
S-1
lrljev4
1 Jul 21
IPO registration
4:05pm
S-1/A
48vxf3xkq so2
19 Jul 21
IPO registration (amended)
6:09am
424B4
unc7p zje249qa
23 Jul 21
Prospectus supplement with pricing info
4:24pm
DRS/A
ed9e40
11 Jun 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next